Stockreport

3 Top Biotech Stocks to Buy in October [The Motley Fool]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Adding these biotech stocks to growth portfolios this month could prove to be profit-friendly. If  Regeneron Pharmaceuticals ( NASDAQ:REGN ) , Incyte Corpo [Read more]